Your browser doesn't support javascript.
loading
T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines.
Kim, Yeongrin; Kim, Ji Eun; Lee, DA Yeon; Choi, Ji U; Park, Jin Song; Lee, Heung Kyoung; Choi, Sang Un; Park, Simon; Park, Chi Hoon.
Afiliação
  • Kim Y; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Kim JE; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, Republic of Korea.
  • Lee DY; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Choi JU; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Park JS; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
  • Lee HK; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Choi SU; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, Republic of Korea.
  • Park S; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Park CH; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
Anticancer Res ; 43(8): 3419-3427, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37500142

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Imunoterapia Adotiva / Membro 14 de Receptores do Fator de Necrose Tumoral / Melanoma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Imunoterapia Adotiva / Membro 14 de Receptores do Fator de Necrose Tumoral / Melanoma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article